119 related articles for article (PubMed ID: 2117504)
1. Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines.
Cahill A; White IN
Carcinogenesis; 1990 Aug; 11(8):1407-11. PubMed ID: 2117504
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) by purified DT-diaphorase under aerobic and anaerobic conditions.
Cahill A; Jenkins TC; White IN
Biochem Pharmacol; 1993 Jan; 45(2):321-9. PubMed ID: 7679576
[TBL] [Abstract][Full Text] [Related]
3. The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver.
Walton MI; Wolf CR; Workman P
Biochem Pharmacol; 1992 Jul; 44(2):251-9. PubMed ID: 1642640
[TBL] [Abstract][Full Text] [Related]
4. Enzymology of the reductive bioactivation of SR 4233. A novel benzotriazine di-N-oxide hypoxic cell cytotoxin.
Walton MI; Workman P
Biochem Pharmacol; 1990 Jun; 39(11):1735-42. PubMed ID: 2344370
[TBL] [Abstract][Full Text] [Related]
5. Initial characterization of the major mouse cytochrome P450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, SR 4233, WIN 59075).
Riley RJ; Hemingway SA; Graham MA; Workman P
Biochem Pharmacol; 1993 Mar; 45(5):1065-77. PubMed ID: 8461036
[TBL] [Abstract][Full Text] [Related]
6. Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductase.
Fitzsimmons SA; Lewis AD; Riley RJ; Workman P
Carcinogenesis; 1994 Aug; 15(8):1503-10. PubMed ID: 8055626
[TBL] [Abstract][Full Text] [Related]
7. Reduction of nitromin to nitrogen mustard: unscheduled DNA synthesis in aerobic or anaerobic rat hepatocytes, JB1, BL8 and Walker carcinoma cell lines.
White IN; Suzanger M; Mattocks AR; Bailey E; Farmer PB; Connors TA
Carcinogenesis; 1989 Nov; 10(11):2113-8. PubMed ID: 2509092
[TBL] [Abstract][Full Text] [Related]
8. Effects of substituted 2-nitroimidazoles and related compounds on unscheduled DNA synthesis in rat hepatocytes and in non-transformed (BL8) and transformed (JB1) rat liver epithelial derived cell lines.
Suzangar M; White IN; Jenkins TC; Connors TA
Biochem Pharmacol; 1987 Nov; 36(21):3743-9. PubMed ID: 3675628
[TBL] [Abstract][Full Text] [Related]
9. Acute lesions in rats caused by 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) or nitromin: a comparison with rates of reduction in microsomal systems from target organs.
White IN; Cahill A; Davies A; Carthew P
Arch Toxicol; 1992; 66(2):100-6. PubMed ID: 1605723
[TBL] [Abstract][Full Text] [Related]
10. 3-amino-1,2,4-benzotriazine 4-oxide: characterization of a new metabolite arising from bioreductive processing of the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
Fuchs T; Chowdhury G; Barnes CL; Gates KS
J Org Chem; 2001 Jan; 66(1):107-14. PubMed ID: 11429885
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.
Patterson AV; Saunders MP; Chinje EC; Talbot DC; Harris AL; Strafford IJ
Br J Cancer; 1997; 76(10):1338-47. PubMed ID: 9374381
[TBL] [Abstract][Full Text] [Related]
12. Genotoxic effects of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and nitrogen mustard-N-oxide (nitromin) in Walker carcinoma cells under aerobic and hypoxic conditions.
Cahill A; Jenkins TC; Pickering P; White IN
Chem Biol Interact; 1995 Mar; 95(1-2):97-107. PubMed ID: 7697757
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studies.
Wang J; Biedermann KA; Wolf CR; Brown JM
Br J Cancer; 1993 Feb; 67(2):321-5. PubMed ID: 8431360
[TBL] [Abstract][Full Text] [Related]
14. Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical.
Lloyd RV; Duling DR; Rumyantseva GV; Mason RP; Bridson PK
Mol Pharmacol; 1991 Sep; 40(3):440-5. PubMed ID: 1654517
[TBL] [Abstract][Full Text] [Related]
15. Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).
Patterson AV; Barham HM; Chinje EC; Adams GE; Harris AL; Stratford IJ
Br J Cancer; 1995 Nov; 72(5):1144-50. PubMed ID: 7577460
[TBL] [Abstract][Full Text] [Related]
16. Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins.
Walton MI; Wolf CR; Workman P
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):983-6. PubMed ID: 2703406
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of SR 4233-induced hepatocyte toxicity under aerobic versus hypoxic conditions.
Silva JM; O'Brien PJ
Br J Cancer; 1993 Sep; 68(3):484-91. PubMed ID: 8394729
[TBL] [Abstract][Full Text] [Related]
18. SR 4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures.
Biedermann KA; Wang J; Graham RP; Brown JM
Br J Cancer; 1991 Mar; 63(3):358-62. PubMed ID: 2003976
[TBL] [Abstract][Full Text] [Related]
19. Enzymology of the reduction of the potent benzotriazine-di-N-oxide hypoxic cell cytotoxin SR 4233 (WIN 59075) by NAD(P)H: (quinone acceptor) oxidoreductase (EC 1.6.99.2) purified from Walker 256 rat tumour cells.
Riley RJ; Workman P
Biochem Pharmacol; 1992 Jan; 43(2):167-74. PubMed ID: 1739405
[TBL] [Abstract][Full Text] [Related]
20. Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554).
Aboagye EO; Lewis AD; Tracy M; Workman P
Biochem Pharmacol; 1997 Dec; 54(11):1217-24. PubMed ID: 9416972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]